Labs / CDMO: development & manufacturing

Isomab
Nottingham, United Kingdom · isomab.bio
GMP
On your own
Free. Their own email.
Through Midgard
Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.
Isomab is a UK-based biopharmaceutical company developing first-in-class antibody therapies for cardiovascular diseases. It is working on ISM-001, an antibody therapeutic for chronic angina that aims to restore collateral vessel growth in the heart, and was spun out of the University of Nottingham in 2022.
They take quote requests by email.
What they offer
Antibody therapy development
Develops first-in-class antibody therapies for cardiovascular diseases.
Cardiovascular drug development
Advances disease-modifying therapeutics for coronary heart disease and chronic angina.
Translational development
Translates VEGF biology into therapies aimed at restoring healthy blood flow in the heart.
What they work on
- Modalities
- Small molecule, Antibody
- Therapeutic areas
- cardiovascular disease, coronary heart disease, chronic angina
- Sites
- Nottingham, United Kingdom
- Serves
- UK, Europe, United States
- Founded
- 2006
Similar labs. Adragos Pharma, ANGITIA, ARSI Canada Inc, Esco Aster
Found in a contract services directory. Listing built from isomab.bio. Work here? Claim this listing.